Why the study?
Do different strains of Coxsackievirus B1 differ in their ability to induce innate immune responses in PBMCs?
Do different strains of Coxsackievirus B1 differ in their ability to induce innate immune responses in PBMCs?
Enterovirus-induced immune activation depends on the specific virus strain, which may modulate the course of infection and play a role in the pathogenesis of chronic immune-mediated diseases such as cardiomyopathies.
Answers are grounded in this paper and cite their sources.
Strain variation in CBV1 IFN-α induction does not alter management; leaves open its role in cardiomyopathy pathogenesis.
Enterovirus infections are usually mild but can also cause severe illnesses and play a role in chronic diseases, such as cardiomyopathies and type 1 diabetes. Host response to the invading virus can markedly modulate the course of the infection, and this response varies between individuals due to the polymorphism of immune response genes. However, it is currently not known if virus strains also differ in their ability to stimulate the host immune system. Coxsackievirus B1 (CBV1) causes severe epidemics in young infants and it has recently been connected with type 1 diabetes in seroepidemiological studies. This study evaluated the ability of different field isolates of CBV1 to induce innate immune responses in PBMCs. CBV1 strains differed markedly in their capacity to induce innate immune responses. Out of the 18 tested CBV1 strains two induced exceptionally strong alpha interferon (IFN-α) response in PBMC cultures. The responding cell type was found to be the plasmacytoid dendritic cell. Such a strong innate immune response was accompanied by an up-regulation of several other immune response genes and secretion of cytokines, which modulate inflammation, and adaptive immune responses. These results suggest that enterovirus-induced immune activation depends on the virus strain. It is possible that the immunotype of the virus modulates the course of the infection and plays a role in the pathogenesis of chronic immune-mediated enterovirus diseases.
No takes yet. Share an insight, caveat, or question.
Hämäläinen et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: